Syngene International Ltd. has the following research output in the current window (1 August 2024 - 31 July 2025) of the Nature Index. Click on Count to view a list of articles representing the ...

BENGALURU and HYDERABAD, India, Oct. 17, 2025 /PRNewswire/ -- Syngene International, a global contract research, development, and manufacturing organization (CRDMO), announced site upgrades to ...

BENGALURU (Reuters) -India's Syngene International Ltd aims to supply half-a-million vials of COVID-19 drug remdesivir through its local distribution partners next month, its top executive said, as ...

BENGALURU, India, Jan. 21, 2026 /PRNewswire/ -- Syngene International, a global contract research, development, and manufacturing organization (CRDMO), today announced the extension of its ...

The new proprietary cell line development platform combines a robust cell line, transposon technology with high throughput clone screening and single cell imaging to deliver highly efficient protein ...

Syngene International Ltd. (NSE: SYNGENE), a leading global contract research, development and manufacturing organization (CRDMO), announces the launch of its new protein production platform. The ...

Syngene International Limited is an integrated research, development and manufacturing services organization serving global pharmaceutical, biotechnology, nutrition, animal health, consumer goods and ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Indian drugmaker Divi's beats profit view for second quarter on API boost Indian drugmaker Divi's Laboratories reported second-quarter profit above analysts' estimates on Friday, helped by its ...

Read the latest Syngene International Ltd NSE share news, written by our expert team of financial journalists. Don't miss today's top SYNN stories.